Dr Reddy’s expects first lot of Russia’s COVID-19 vaccine Sputnik V by May end

By: |
Updated: April 27, 2021 12:19 PM

Dr Reddy's Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccineSputnik V, on Tuesday said it expects the first lot of stock from Russian Direct Investment Fund by May end.

Russia's Sputnik V vaccine, Russian Direct Investment Fund, Sr Reddy labRussia's single dose Sputnik Covid-19 vaccine to reach India

Dr Reddy’s Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccineSputnik V, on Tuesday said it expects the first lot of stock from Russian Direct Investment Fund by May end. In September 2020, Dr Reddys and RDIF entered into a partnership to conduct clinical trials of SputnikV, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the rights for distribution of the first 100 million doses in India. Later, it was enhanced to 125 million.

“We are targeting to have the first batches imported by Q1, and are trying our best to have them by end-May,” A Dr Reddy’s spokesperson told PTI in an email reply. RDIF CEO Kirill Dmitriev in a virtual press conference recently said he expected over 50 million doses of SputnikV vaccine to be manufactured in India by this summer.

He had said RDIF has tied up with five drug companies for the vaccine and is looking at a couple of more firms for the possible production pacts. Once available, SputnikV will be the third vaccine to be used in India against coronavirus. In January, DCGI had given the emergency use authorisation for two COVID-19 vaccines — Covaxin of Bharat Biotech and Covishield of Oxford-AstraZeneca manufactured by Serum Institute of India in Pune. “We expect Domestic Manufacturing to ramp up from Q2.
We are not able to confirm on the first lot size at this time,” Dr Reddy’s official further said.

A senior official of Dr Reddy’s said the vaccine will be imported in a frozen condition from RDIF maintaining -18 to -22 degree celsius.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Coronavirus in India Live Updates: India reports 2.81 lakh new Covid-19 cases, death count remains over 4,000
2South Africa launches plan to vaccinate 5 million citizens, at risk of COVID death, by June
3UP gearing up to tackle Covid’s possible 3rd wave, black fungus infection: CM Yogi Adityanath